ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1420

A Nationwide Analysis of In-Hospital Mortality in Adult Ankylosing Spondylitis

Isadora Small1, Anuya Natu2 and Augustine Manadan3, 1The Latin School of Chicago, Chicago, IL, 2John H Stroger, Jr. Hospital of Cook County, Chicago, IL, 3Rush University Medical Center, Chicago, IL

Meeting: ACR Convergence 2025

Keywords: Ankylosing spondylitis (AS), Mortality, spondyloarthritis, Spondyloarthropathies, Trauma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1405–1433) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Ankylosing spondylitis (AS) is a chronic inflammatory disease with systemic complications that may contribute to increased mortality risk. This study examines the characteristics and causes of in-hospital death among adult AS patients in the United States using a claims-based database.

Methods: A retrospective analysis of all adult hospitalizations with a diagnosis of AS (ICD-10: M45) in the National Inpatient Sample (NIS) database (2017 – 2021) was conducted. Descriptive statistics were used to analyze demographics, hospital length of stay (LOS), insurance status, total hospital charges, and causes of death categorized by ICD-10 codes.

Results: Of the 96,330 adult AS hospitalizations in the 2017 – 2021 NIS database, 2,390 (2.5%) died in the hospital (Table 1). AS patients who died compared to those discharged alive were more likely to be male (79.7% vs. 62.9%; p < 0.001), were older (median age 73 vs. 62 years; p < 0.001), had longer median hospital LOS (7 vs. 4 days; p < 0.001), had higher median total hospital charges ($104,275 vs. $44,345; p < 0.001), more Medicare (73.6% vs. 54.6%; p < 0.001), less Medicaid (4.8% vs. 10.3%; p < 0.001), less private insurance (16.3% vs. 30.1%; p < 0.001), and a lower percentage of the top household income quartile (18.6% vs. 24.9%; p = 0.002). Racial distribution did not significantly differ between groups.The causes of in-hospital death of AS patients as determined by their “principal ICD-10 billing diagnosis category” were as follows: injury/poisoning (29.1%), infections (22.0%), cardiovascular (CV) diseases (11.3%), respiratory diseases (11.1%), hematologic/oncologic conditions (7.5%), gastrointestinal diseases (5.0%), genitourinary diseases (3.1%), factors influencing health status (1.5%), rheumatologic diseases (1.3%), neurologic diseases (0.8%), endocrine diseases (0.6%), and other causes (0.6%) (Table 2).The most common specific injury diagnosis was traumatic subdural hemorrhage (ICD-10: S06.5X0A) (table 3), followed by fractures of the thoracic (ICD-10: S22.089A, S22.088A, S22.078A, S22.069A, S22.079A), cervical (ICD-10: S12.300A, S12.400A, S12.490A, S12.200A), and lumbar vertebrae (ICD-10: S32.019A). Severe spinal cord injuries (ICD-10: S14.115A, S24.102A, S24.103A, S14.106A), traumatic subarachnoid hemorrhage (ICD-10: S06.6X0A), and thoracic trauma, including hemothorax and hemopneumothorax (ICD-10: S27.1XXA, S27.2XXA), were also frequent (Table 3).

Conclusion: Our analysis represents the only report to date to comprehensively study AS inpatients on a U.S. national level. Over 1 of 50 AS hospitalizations ended in death, and they were predominantly older males, most of whom had Medicare insurance. Injury-related conditions were the most frequent cause of death. The leading injury diagnoses were brain bleeds, vertebral fractures, and spinal cord injuries. Further research is needed to explore the factors contributing to injuries and falls in AS patients.

Supporting image 1Table 1. Descriptive Characteristics of Adult Ankylosing Spondylitis Patients from 2017 – 2021 National Inpatient Sample Database (n = 96,330).

Abbreviations: AS = ankylosing spondylitis; n = number; IQR = interquartile range

Supporting image 2Table 2. Causes for In-Hospital Death of Adult Ankylosing Spondylitis Patients from the National Inpatient Sample Database 2017 – 2021 (n = 2,390).

Abbreviations: AS = ankylosing spondylitis; n = number; NR = not reported as below permitted reporting threshold rules for National Inpatient Sample

Supporting image 3Table 3: Top Injury Causes of In-Hospital Death in Adult AS patients from National Inpatient Sample Database.


Disclosures: I. Small: None; A. Natu: None; A. Manadan: None.

To cite this abstract in AMA style:

Small I, Natu A, Manadan A. A Nationwide Analysis of In-Hospital Mortality in Adult Ankylosing Spondylitis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/a-nationwide-analysis-of-in-hospital-mortality-in-adult-ankylosing-spondylitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-nationwide-analysis-of-in-hospital-mortality-in-adult-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology